Other Income & Expense
Other Income (Expense)
Neurocrine Biosciences Other Income (Expense) increased by 87.4% to $53.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 700.0%, from -$8.90M to $53.40M.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Detailed definition
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Peer comparison
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
Metric ID:
other_income_expense_netHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$5.30M | -$14.00M | $18.30M | -$78.00M | $10.10M | $10.90M | $48.00M | -$25.60M | $47.90M | -$64.80M | -$46.80M | $6.50M | -$8.90M | $13.90M | $52.80M | $28.50M | $53.40M |
| QoQ Change | — | -164.2% | +230.7% | -526.2% | +112.9% | +7.9% | +340.4% | -153.3% | +287.1% | -235.3% | +27.8% | +113.9% | -236.9% | +256.2% | +279.9% | -46.0% | +87.4% |
| YoY Change | — | — | — | <-999% | +172.1% | -40.4% | +161.5% | -353.5% | — | -694.5% | -197.5% | +125.4% | +86.3% | +129.7% | +712.3% | — | +700.0% |
Range-$78.00M – $53.40M
CAGR+78.2%
Avg YoY Growth-47.5%
Median YoY Growth+105.8%
Other Income (Expense) at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's other income (expense)?
- Neurocrine Biosciences (NBIX) reported other income (expense) of $53.40M in Q1 2026.
- How has Neurocrine Biosciences's other income (expense) changed year-over-year?
- Neurocrine Biosciences's other income (expense) increased by 700.0% year-over-year, from -$8.90M to $53.40M.
- What does other income (expense) mean?
- The net result of all income and expenses not related to core business operations.